CI Quote, Financials, Valuation and Earnings

Elevance Health has a net margin of 2.02% compared to The Cigna Group's net margin of 4.47%. The Cigna Group's return on equity of 12.17% beat Elevance Health's return on equity of 14.03%.

The Cigna Group has a consensus price target of $375.34, signalling upside risk potential of 19.37%. On the other hand Elevance Health has an analysts' consensus of $500.75 which suggests that it could grow by 32.99%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.437, which suggesting that the stock is 56.294% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.674%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.85%. Elevance Health offers a yield of 1.77% to investors and pays a quarterly dividend of $1.71 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Elevance Health quarterly revenues of $48.9B. The Cigna Group's net income of $1.3B is lower than Elevance Health's net income of $2.2B. Notably, The Cigna Group's price-to-earnings ratio is 17.41x while Elevance Health's PE ratio is 14.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.34x versus 0.48x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Eli Lilly and has a net margin of 2.02% compared to The Cigna Group's net margin of 21.68%. The Cigna Group's return on equity of 12.17% beat Eli Lilly and's return on equity of 78.25%.

The Cigna Group has a consensus price target of $375.34, signalling upside risk potential of 19.37%. On the other hand Eli Lilly and has an analysts' consensus of $951.98 which suggests that it could grow by 17.88%. Given that The Cigna Group has higher upside potential than Eli Lilly and, analysts believe The Cigna Group is more attractive than Eli Lilly and.

The Cigna Group has a beta of 0.437, which suggesting that the stock is 56.294% less volatile than S&P 500. In comparison Eli Lilly and has a beta of 0.404, suggesting its less volatile than the S&P 500 by 59.63%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.85%. Eli Lilly and offers a yield of 0.69% to investors and pays a quarterly dividend of $1.50 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Eli Lilly and pays out 44.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Eli Lilly and quarterly revenues of $12.7B. The Cigna Group's net income of $1.3B is lower than Eli Lilly and's net income of $2.8B. Notably, The Cigna Group's price-to-earnings ratio is 17.41x while Eli Lilly and's PE ratio is 65.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.34x versus 14.89x for Eli Lilly and. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 2.02% compared to The Cigna Group's net margin of 2.67%. The Cigna Group's return on equity of 12.17% beat Molina Healthcare's return on equity of 25.66%.

The Cigna Group has a consensus price target of $375.34, signalling upside risk potential of 19.37%. On the other hand Molina Healthcare has an analysts' consensus of $359.49 which suggests that it could grow by 23.86%. Given that Molina Healthcare has higher upside potential than The Cigna Group, analysts believe Molina Healthcare is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.437, which suggesting that the stock is 56.294% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.564, suggesting its less volatile than the S&P 500 by 43.589%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.85%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Molina Healthcare quarterly revenues of $11.1B. The Cigna Group's net income of $1.3B is higher than Molina Healthcare's net income of $298M. Notably, The Cigna Group's price-to-earnings ratio is 17.41x while Molina Healthcare's PE ratio is 14.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.34x versus 0.39x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.02% compared to The Cigna Group's net margin of 5.74%. The Cigna Group's return on equity of 12.17% beat UnitedHealth Group's return on equity of 21.74%.

The Cigna Group has a consensus price target of $375.34, signalling upside risk potential of 19.37%. On the other hand UnitedHealth Group has an analysts' consensus of $385.34 which suggests that it could grow by 25.25%. Given that UnitedHealth Group has higher upside potential than The Cigna Group, analysts believe UnitedHealth Group is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.437, which suggesting that the stock is 56.294% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.442, suggesting its less volatile than the S&P 500 by 55.841%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.85%. UnitedHealth Group offers a yield of 2.77% to investors and pays a quarterly dividend of $2.21 per share. The Cigna Group pays 45.63% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. The Cigna Group's net income of $1.3B is lower than UnitedHealth Group's net income of $6.3B. Notably, The Cigna Group's price-to-earnings ratio is 17.41x while UnitedHealth Group's PE ratio is 12.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.34x versus 0.69x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.